Skye Bioscience, Inc.

NasdaqGM:SKYE 주식 보고서

시가총액: US$168.7m

Skye Bioscience 관리

관리 기준 확인 2/4

Skye Bioscience's CEO is Punit Dhillon, appointed in Aug 2020, has a tenure of 4.25 years. total yearly compensation is $1.81M, comprised of 24.9% salary and 75.1% bonuses, including company stock and options. directly owns 0.15% of the company’s shares, worth $244.81K. The average tenure of the management team and the board of directors is 2.5 years and 0.7 years respectively.

주요 정보

Punit Dhillon

최고 경영자

US$1.8m

총 보상

CEO 급여 비율24.9%
CEO 임기4.3yrs
CEO 소유권0.1%
경영진 평균 재임 기간2.5yrs
이사회 평균 재임 기간less than a year

최근 관리 업데이트

Recent updates

Skye: Moving Weight Loss Drugs To The Next Level

Sep 04

Is Skye Bioscience (NASDAQ:SKYE) Using Debt In A Risky Way?

Aug 11
Is Skye Bioscience (NASDAQ:SKYE) Using Debt In A Risky Way?

CEO 보상 분석

Punit Dhillon 의 보수는 Skye Bioscience 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-US$42m

Mar 31 2024n/an/a

-US$37m

Dec 31 2023US$2mUS$450k

-US$38m

Sep 30 2023n/an/a

-US$43m

Jun 30 2023n/an/a

-US$21m

Mar 31 2023n/an/a

-US$22m

Dec 31 2022US$668kUS$433k

-US$19m

Sep 30 2022n/an/a

-US$12m

Jun 30 2022n/an/a

-US$11m

Mar 31 2022n/an/a

-US$9m

Dec 31 2021US$900kUS$400k

-US$9m

Sep 30 2021n/an/a

-US$8m

Jun 30 2021n/an/a

-US$7m

Mar 31 2021n/an/a

-US$6m

Dec 31 2020US$615kUS$160k

-US$7m

Sep 30 2020n/an/a

-US$207k

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

US$13m

Dec 31 2019US$65kn/a

US$1m

Sep 30 2019n/an/a

-US$10m

Jun 30 2019n/an/a

-US$7m

Mar 31 2019n/an/a

-US$26m

Dec 31 2018US$82kn/a

-US$19m

보상 대 시장: Punit's total compensation ($USD1.81M) is about average for companies of similar size in the US market ($USD1.48M).

보상과 수익: Punit's compensation has increased whilst the company is unprofitable.


CEO

Punit Dhillon (44 yo)

4.3yrs

테뉴어

US$1,807,338

보상

Mr. Punit S. Dhillon, BA, has been Chief Executive Officer of Skye Bioscience, Inc. since August 10, 2020. Mr. Dhillon serves as Chair of Skye Bioscience, Inc. until October 25, 2024. He served as Principa...


리더십 팀

이름위치테뉴어보상소유권
Punit Dhillon
President4.3yrsUS$1.81m0.15%
$ 244.8k
Kaitlyn Arsenault
Chief Financial Officer3.1yrsUS$1.27m0.13%
$ 220.4k
Christopher Twitty
Chief Scientific Officer1.9yrs데이터 없음데이터 없음
Tu Diep
Chief Development Officerno data데이터 없음0.0088%
$ 14.8k
Puneet Arora
Chief Medical Officerless than a year데이터 없음데이터 없음

2.5yrs

평균 재임 기간

43.5yo

평균 연령

경험이 풍부한 관리: SKYE's management team is considered experienced (2.5 years average tenure).


이사회 구성원

이름위치테뉴어보상소유권
Punit Dhillon
President6.8yrsUS$1.81m0.15%
$ 244.8k
Paul Grayson
Independent Chairman of the Board1.3yrsUS$1.25m0.077%
$ 129.7k
Andrew Schwab
Director1.3yrsUS$74.08k0%
$ 0
Louis Aronne
Member of Clinical & Scientific Advisory Boardless than a year데이터 없음데이터 없음
Annalisa Lisa Jenkins
Independent Directorless than a year데이터 없음0%
$ 0
Karen Smith
Directorless than a year데이터 없음0%
$ 0
Deborah Charych
Independent Director1.8yrsUS$102.28k0%
$ 0
Rekha Kumar
Member of Clinical & Scientific Advisory Boardless than a year데이터 없음데이터 없음
Lee Kaplan
Member of Clinical & Scientific Advisory Boardless than a year데이터 없음데이터 없음
Beverly Tchang
Member of Clinical & Scientific Advisory Boardless than a year데이터 없음데이터 없음
Marcus Goncalves
Member of Clinical & Scientific Advisory Boardless than a year데이터 없음데이터 없음

0.7yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 이사회: SKYE's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.